Please assess the completion status of the following clinical trial:

Trial Title: Assessing the Tolerability of Oligosaccharide Supplementation in Patients With Crohn's Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* age \>/= 19 years~* diagnosed with CD for \>/= 6 months, currently in remission based on the Harvey-Bradshaw Index score (\</= 4 points) and C-reactive protein (\<5mg/L)~Exclusion Criteria:~* unable to provide informed consent;~* have significant hepatic, renal, endocrine, respiratory, neurological, or cardiovascular disease;~* confirmed diagnosis of celiac disease, or have suspected celiac disease and are following a gluten-free diet to manage symptoms with an elevated screening anti-tissue transglutaminase antibody test;~* significant complications of CD which includes a history of extensive colonic resection, including subtotal or total colectomy, history of \>/= 3 small bowel resections or received a diagnosis of short bowel syndrome, current ileostomy, colostomy or ileal-anal pouch, or a fixed symptomatic intestinal stenosis;~* antibiotic use in the 4 weeks prior to study start;~* use of any rectal preparations in the 2 weeks prior to study start;~* use of any non-steroidal anti-inflammatory drugs in the 2 weeks prior to study start;~* use of commercial probiotic supplements in the 4 weeks prior to study start~* change in CD therapy in the 4 weeks prior to study start (excluding steroid taper, however steroid dosing must be stable for 2 weeks prior to study start);~* recently been adhering to a novel dietary intervention for alternative health issues within the last 4 weeks prior to study start.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): 1 placebo muesli bars and 1 serving placebo muesli per day (0.55 g total fructans/GOS)
- Moderate Oligosaccharide Group (Type: EXPERIMENTAL): 1 placebo muesli bar and 1 serving intervention muesli per day (3.25 g total fructans/GOS)
- High Oligosaccharide Group (Type: EXPERIMENTAL): 1 intervention muesli bar and 1 serving intervention muesli per day (5.43 total fructans/GOS)

Based on this trial design, predict the completion outcome and termination type (if applicable).